GGrantIndex
← Leaderboards

Carlos G Grijalva

Vanderbilt University Medical Center

$7,760,476
Attributed
$11,875,972
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,498,235 · 7
AHRQ$3,691,374 · 3
CDC$2,686,363 · 2

By mechanism

T32$3,542,045 · 1
R01$2,262,265 · 1
U01$2,249,290 · 1
R21$1,446,099 · 3
K24$893,010 · 1
D43$745,169 · 1

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionPreventionVaccinationCohort StudiesBaseClinically RelevantFollow-UpVaccinesTrainingElderlyPharmacoepidemiologyHospitalizationInfluenzaPatternTransmission ProcessHouseholdRespiratoryChildSymptomsDesignPrevention StrategyMemberAffectModernization

Grant awards (42)

Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program$247,072
D43 · FY2025 · TW · contact PI
Learning Health System training program: PROgRESS-- Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$579,788
T32 · FY2024 · HS
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program$246,719
D43 · FY2024 · TW · contact PI
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease$224,548
R21 · FY2024 · AI
Mentoring in transmission of influenza and strategies for prevention$178,602
K24 · FY2024 · AI · contact PI
Learning Health System training program: PROgRESS-- Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$540,033
T32 · FY2023 · HS
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease$270,051
R21 · FY2023 · AI
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program$251,378
D43 · FY2023 · TW · contact PI
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes$216,250
R21 · FY2023 · AI
Mentoring in transmission of influenza and strategies for prevention$178,602
K24 · FY2023 · AI · contact PI
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$531,729
T32 · FY2022 · HS
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes$259,500
R21 · FY2022 · AI
Gestational diabetes drugs and perinatal outcomes in underserved populations$259,500
R21 · FY2022 · HD
Mentoring in transmission of influenza and strategies for prevention$178,602
K24 · FY2022 · AI · contact PI
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$437,799
T32 · FY2021 · HS
Gestational diabetes drugs and perinatal outcomes in underserved populations$216,250
R21 · FY2021 · HD
Mentoring in transmission of influenza and strategies for prevention$178,602
K24 · FY2021 · AI · contact PI
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$536,709
T32 · FY2020 · HS
Mentoring in transmission of influenza and strategies for prevention$178,602
K24 · FY2020 · AI · contact PI
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$575,658
T32 · FY2019 · HS
Household Transmission of Influenza Viruses in the Community-COVID 19 Supplement$500,000
U01 · FY2019 · IP · contact PI
Household Transmission of Influenza Viruses in the Community$500,000
U01 · FY2019 · IP · contact PI
Household Transmission of Influenza Viruses in the Community$250,000
U01 · FY2019 · IP · contact PI
Household Transmission of Influenza Viruses in the Community$499,639
U01 · FY2018 · IP · contact PI
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science$340,329
T32 · FY2018 · HS
Household Transmission of Influenza Viruses in the Community$499,651
U01 · FY2017 · IP · contact PI
Opioid selection and the risk of serious infections in older adults$295,760
R01 · FY2017 · AG · contact PI
Opioid selection and the risk of serious infections in older adults$296,975
R01 · FY2016 · AG · contact PI
Opioid selection and the risk of serious infections in older adults$414,901
R01 · FY2015 · AG · contact PI
Opioid selection and the risk of serious infections in older adults$130,602
R01 · FY2015 · AG · contact PI
The Impact of Infant Vaccination with a 13-valent Pneumococcal Conjugate Vaccine$35,596
R03 · FY2015 · HS · contact PI
The Impact of Infant Vaccination with a 13-valent Pneumococcal Conjugate Vaccine$14,281
R03 · FY2015 · HS · contact PI
Opioid selection and the risk of serious infections in older adults$555,860
R01 · FY2014 · AG · contact PI
The Impact of Infant Vaccination with a 13-valent Pneumococcal Conjugate Vaccine$50,011
R03 · FY2014 · HS · contact PI
Opioid selection and the risk of serious infections in older adults$568,167
R01 · FY2013 · AG · contact PI
Opiod Analgesics and the Risk of Serious Infections in Seniors$73,701
R03 · FY2013 · AG · contact PI
Opiod Analgesics and the Risk of Serious Infections in Seniors$77,991
R03 · FY2012 · AG · contact PI
Evaluating the Impact of a Large School-based Influenza Immunization Campaign$138,209
K01 · FY2009 · IP · contact PI
Evaluating the Impact of a Large School-based Influenza Immunization Campaign$149,432
K01 · FY2008 · IP · contact PI
The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations$94
R03 · FY2008 · HS · contact PI
Evaluating the Impact of a Large School-based Influenza Immunization Campaign$149,432
K01 · FY2007 · IP · contact PI
The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations$49,347
R03 · FY2007 · HS · contact PI